Skip to main navigation Skip to search Skip to main content

Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT study

  • Soo Lim
  • , Cheol Young Park
  • , In Kyung Jeong
  • , Ji Sung Yoon
  • , Sang Yong Kim
  • , Eun Seok Kang
  • , Junghyun Noh
  • , Kyu Yeon Hur
  • , Sungrae Kim
  • Seoul National University
  • Kangbuk Samsung Hospital
  • Kyung Hee University
  • Yeungnam University
  • Chosun University
  • Yonsei University
  • Inje University
  • The Catholic University of Korea

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science